can semaglutide cause heart problems In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for failure or all-cause mortality vs sitagliptin, but tirzepatide offered no additional benefit over semaglutide. https://ja.ma/3JO2SQc Semaglutide in Cardiometabolic Diseases: SELECTing

The generic name for Zepbound is tirzepatide, which is the active pharmaceutical ingredient and nonproprietary name used in scientific literature and regulatory documentation

Levin D, Bell S, Sund R, Hartikainen SA, Tuomilehto J, Pukkala E, Keskimaki I, Badrick E, Renehan AG, Buchan IE, Bowker SL, Minhas-Sandhu JK, Zafari Z, Marra C, Johnson JA, Stricker BH, Uitterlinden AG, Hofman A, Ruiter R, de Keyser CE, MacDonald TM, Wild SH, McKeigue PM, Colhoun HM

Although GLP-1 receptor agonists are generally well tolerated in metabolic populations, they are associated with potential side effects such as gastrointestinal discomfort, nausea, and appetite changes

Glucagon-like peptides (GLPs) GLP-1 is a 31 amino acid peptide that acts as an incretin hormone, potentiating the release of insulin